FI
CCXI

Fosun International’s ChemoCentryx, Inc. CCXI Stock Holding History

Fosun International’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-128,637
Closed -$1.15M – 312
2019
Q2 		$1.15M Buy
128,637
+36,861
+40% +$427K 0.08% 150
2019
Q1 		$1.22M Sell
91,776
-9,200
-9% -$105K 0.08% 141
2018
Q4 		$1.06M Sell
100,976
-58,074
-37% -$612K 0.06% 129
2018
Q3 		$1.72M Buy
+159,050
New +$1.92M 0.08% 104

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fosun International's CCXI Position: Q3 2019 in Review

Fosun International sold out of ChemoCentryx, Inc. (CCXI) in Q3 2019, closing a stake of 128,637 shares — an estimated $1.15M sold.

Fosun International first reported a position in CCXI in Q3 2018 and held it in 4 quarters. The position peaked at $1.72M in Q3 2018. 100 funds tracked by Wall St. Rank hold CCXI as of Q3 2019.

  • Fosun International reported no remaining ChemoCentryx, Inc. position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 128,637 ChemoCentryx, Inc. shares in Q3 2019, an estimated $1.15M.
  • Fosun International first reported a position in ChemoCentryx, Inc. in Q3 2018 and held it in 4 quarters.
  • Fosun International's ChemoCentryx, Inc. position peaked at $1.72M in Q3 2018.
  • 100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.